ANI PHARMACEUTICALS, INC (ANIP)

Import this data to Google Sheets with:

=jivedata("ANIP","financials")

Full statements spill as a table. For one cell: =jivedata("ANIP","Revenue") or =jivedata("ANIP","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

ANI PHARMACEUTICALS, INC

ANIP • CIK 0001023024

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$486,816	$614,376	$883,366	$978,379
Operating Income (Loss)	$46,971	$584	$111,093	$150,355
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$19,872	$-22,212	$95,791	$142,597
Income Tax Expense (Benefit)	$1,093	$-3,690	$17,454	$34,287
Net Income (Loss) Attributable to Parent	$18,779	$-18,522	$78,337	$108,310
Preferred Stock Dividends, Income Statement Impact	$1,625	$1,625	$1,157	$344
Net Income (Loss) Available to Common Stockholders, Basic	$17,154	$-20,147	$77,180	$104,192
Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization	$181,513	$250,210	$341,310	$387,398
Research and Development Expense	$34,286	$44,581	$51,664	$49,912
Selling, General and Administrative Expense	$161,697	$249,636	$317,745	$324,762
Depreciation, Depletion and Amortization, Nonproduction	$59,791	$67,731	$91,417	$85,804
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability	$1,426	$-619	$-31,012	$-21,001
Gain (Loss) on Disposition of Assets	—	—	$-382	$-382
Restructuring and Related Cost, Incurred Cost	$1,132	$0	$0	$0
Costs and Expenses	$439,845	$613,792	$772,273	$828,024
Equity Securities, FV-NI, Unrealized Gain (Loss)	—	$6,307	$2,824	$9,907
Interest Income (Expense), Nonoperating, Net	$-26,940	$-17,602	$-20,060	$-16,543
Other Nonoperating Income (Expense)	$-159	$-4,033	$1,934	$-1,122
Gain (Loss) on Extinguishment of Debt	$0	$-7,468	$0	$0
Weighted Average Number of Shares Outstanding, Basic	18,001,000	19,318,000	20,053,000	21,368,000
Weighted Average Number of Shares Outstanding, Diluted	18,194,000	19,318,000	21,228,000	22,836,000
Undistributed Earnings (Loss) Allocated to Participating Securities, Basic	$1,679	$0	$6,963	$8,369
Undistributed Earnings, Basic	$15,475	$-20,147	$70,217	$83,935
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	2,400,000	2,300,000	2,000,000	1,200,000
Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted	$1,663	$0	$6,611	$7,945
Undistributed Earnings, Diluted	$15,491	$-20,147	$70,569	$100,021
Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements	193,000	0	1,175,000	1,468,000

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$221,121	$144,861	$285,585	$360,212
Restricted Cash, Current	$0	$33	$36	$35
Accounts Receivable, after Allowance for Credit Loss, Current	$162,079	$221,726	$281,082	$274,469
Assets	$904,422	$1,283,697	$1,440,377	$1,494,112
Inventory, Net	$111,196	$136,782	$143,067	$143,149
Prepaid Expense, Current	$17,400	$17,975	$23,189	$31,942
Equity Securities, FV-NI, Cost	—	$6,307	$9,131	$15,626
Assets, Current	$519,816	$527,684	$753,117	$825,433
Property, Plant and Equipment, Net	$44,593	$56,863	$62,476	$73,223
Deferred Income Tax Assets, Net	$90,711	$85,106	$69,072	$71,495
Intangible Assets, Net (Excluding Goodwill)	$209,009	$541,834	$479,526	$449,857
Liabilities	$446,823	$855,167	$899,653	$896,900
Goodwill	$28,221	$59,990	$62,480	$62,480
Other Assets, Noncurrent	$12,072	$12,220	$13,706	$11,624
Long-term Debt, Current Maturities	$850	$9,172	$17,268	$21,329
Accounts Payable, Current	$36,683	$45,656	$62,583	$73,830
Accrued Royalties, Current	$16,276	$22,626	$48,497	$55,830
Employee-related Liabilities, Current	$23,786	$37,725	$37,897	$27,154
Taxes Payable, Current	$8,164	$6,749	$1,291	$3,532
Business Combination, Contingent Consideration, Liability, Current	$12,266	$29	$167	$167
Accrued Liabilities, Current	$5,606	$13,735	$16,803	$16,575
Liabilities, Current	$145,477	$193,680	$278,112	$283,655
Long-term Debt, Excluding Current Maturities	$284,819	$309,108	$291,840	$280,155
Business Combination, Contingent Consideration, Liability, Noncurrent	$11,718	$19,825	$9,610	$8,546
Other Liabilities, Noncurrent	$4,809	$5,781	$12,164	$15,535
Temporary Equity, Carrying Amount, Attributable to Parent	$24,850	$24,850	$0	$0
Common Stock, Value, Issued	$2	$2	$3	$3
Preferred Stock, Value, Issued	$0	$0	$0	$0
Treasury Stock, Common, Value	$10,081	$21,040	$33,249	$53,817
Additional Paid in Capital	$514,103	$519,653	$596,036	$620,249
Retained Earnings (Accumulated Deficit)	$-80,132	$-100,279	$-23,099	$31,104
Accumulated Other Comprehensive Income (Loss), Net of Tax	$8,857	$5,344	$1,033	$-327
Stockholders' Equity Attributable to Parent	$432,749	$403,680	$540,724	$597,212
SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount	$97,262	$127,824	$171,803	$171,803
Temporary Equity, Shares Outstanding	—	—	25,000	25,000
Common Stock, Shares Authorized	—	—	66,000,000	66,000,000
Common Stock, Shares, Issued	—	—	23,112,577	23,112,577
Common Stock, Shares, Outstanding	—	—	22,491,281	22,491,281
Preferred Stock, Shares Authorized	1,666,667	1,666,667	1,666,667	1,666,667
Preferred Stock, Shares Issued	0	0	0	0
Treasury Stock, Common, Shares	263,943	429,555	621,296	891,915

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	—	$-470	$-233	$-554
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$167,887	$-76,227	$140,727	$142,414
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$221,121	$144,894	$285,621	$446,997
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$18,779	$-18,522	$78,337	$108,310
Net Cash Provided by (Used in) Operating Activities	$118,959	$64,017	$185,225	$189,466
Payments to Acquire Businesses, Net of Cash Acquired	$0	—	—	—
Payments to Acquire Intangible Assets	$9,643	$717	$20,486	$5,469
Payments to Acquire Property, Plant, and Equipment	$8,868	$16,236	$13,835	$16,475
Proceeds from Sale of Buildings	—	$13,514	$0	$0
Net Cash Provided by (Used in) Investing Activities	$-18,511	$-404,719	$-34,321	$-21,944
Proceeds from Convertible Debt	—	$316,250	$0	$0
Proceeds from Long-term Lines of Credit	$0	$325,000	$0	$0
Payments for Derivative Instrument, Financing Activities	—	$40,575	$0	$0
Proceeds from Issuance of Common Stock	$80,555	$0	$0	$0
Payment for Contingent Consideration Liability, Financing Activities	$12,500	$12,500	$26	$106
Repayments of Other Long-term Debt	$0	$3,531	$10,156	$14,219
Payments of Debt Issuance Costs	—	$17,353	$0	$0
Repayments of Lines of Credit	$0	$292,500	$0	$0
Payments of Dividends	$1,625	$1,625	$1,157	$344
Proceeds from Stock Options Exercised	$8,996	$6,488	$13,604	$12,338
Payments for Repurchase of Common Stock	$4,987	$10,959	$12,209	$22,223
Net Cash Provided by (Used in) Financing Activities	$67,439	$264,945	$-9,944	$-24,554
Cash and Cash Equivalents, at Carrying Value	$221,121	$144,861	$285,585	$446,959
Restricted Cash, Current	$0	$33	$36	$38
Interest Paid, Excluding Capitalized Interest, Operating Activities	$31,431	$24,379	$26,929	$25,309
Income Taxes Paid	$1,228	$19,061	$17,674	$17,674
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	$4,715	$0	$6,641	$6,641
Noncash or Part Noncash Acquisition, Other Liabilities Assumed	$0	$8,322	$0	$0
Conversion of Stock, Amount Converted	—	—	$24,850	$24,850
Capital Expenditures Incurred but Not yet Paid	$328	$529	$1,050	$6,807
Share-based Payment Arrangement, Noncash Expense	$20,652	$29,344	$37,929	$41,056
Deferred Income Taxes and Tax Credits	$-11,740	$-21,913	$14,237	$18,733
Other Depreciation and Amortization	$59,791	$67,731	$91,417	$89,445
Equity Securities, FV-NI, Unrealized Gain (Loss)	—	$6,307	$2,824	$9,907
Operating Lease, Right-of-Use Asset, Amortization Expense	$1,269	$1,526	$1,759	$1,822
Amortization of Debt Issuance Costs and Discounts	$3,922	$642	$1,356	$1,406
Gain (Loss) on Disposition of Other Assets	—	$5,347	$-382	$-382
Gain (Loss) on Extinguishment of Debt	$0	$-7,468	$0	$0
Asset Impairment Charges	$0	$7,600	$767	$767
Increase (Decrease) in Accounts Receivable	$-3,359	$21,087	$58,530	$48,370
Increase (Decrease) in Inventories	$5,841	$21,287	$5,961	$4,560
Increase (Decrease) in Prepaid Expense	$9,015	$-2,129	$5,024	$18,561
Increase (Decrease) in Accounts Payable	$7,552	$479	$15,156	$10,773
Increase (Decrease) in Income Taxes	$11,991	$-1,415	$-15,531	$241

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("ANIP","financials")

Full statements spill as a table. For one cell: =jivedata("ANIP","Revenue") or =jivedata("ANIP","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.